Sorrento Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sorrento Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2021 | 2021-11-05 | $-0.40 | $-0.21 | -90.5 % |
Jun 2021 | 2021-08-06 | $-0.57 | $-0.20 | -185.0 % |
Mar 2021 | 2021-05-05 | $0.01 | $0.24 | -95.8 % |
Jun 2020 | 2020-08-04 | $-0.36 | $-0.24 | -50.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2021 | 2021-11-05 | $12.06M | $10.21M | 18.1 % |
Jun 2021 | 2021-08-06 | $13.51M | $10.13M | 33.4 % |
Mar 2021 | 2021-05-05 | $14.26M | $17.25M | -17.4 % |
Jun 2020 | 2020-08-04 | $9.01M | $7.90M | 14.0 % |
Sorrento Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3.
Sorrento Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3 and the Actual EPS was $-0.20, which missed the estimate of $0.00.
Sorrento Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.